PREVENT IV trial participants who had undergone either a RIMA or LIMA to LAD anastomosis and underwent an angiogram at 1 to 1.5 years (n=1539) were analyzed for mammary graft failure (defined as >75% stenosis).
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary disease
December 16, 2015
December 10, 2015
A growing body of evidence demonstrates improved short, mid, and long term outcomes with the use of arterial conduits for coronary revascularization. Despite this, less than 10% of patients receive more than 2 arterial grafts.
November 30, 2015
This is an expert commentary on the state of the art in this field together with an audio commentary also available on this link
November 17, 2015
The authors report on the extended follow-up of Courage Trial patients for up to 15 years. In this trial, patients with chronic stable angina were randomized to medical therapy alone versus PCI plus medical therapy. At extended follow-up, there was no difference in overall survival between the two treatment strategies.
November 11, 2015
The timing and dosage of preoperative ASA administration was evaluated with regard to CABG outcomes in a series of 3018 pts. Dosing within 24 hrs of surgery was associated with a 50% lower mortality rate and an 81mg dose was associated with a 50% or greater reduction in mortality compared to a 325mg dose or no ASA.
October 29, 2015
Using University of Michigan Health and Retirement Study data, the authors evaluated marital status at the time of cardiac surgery and subsequent survival or deterioration in the ability to perform activities of daily living (ADLs) independently. At follow-up, those who were married had a 19.4% incidence of death or new disability, which was simila
October 5, 2015
Pts undergoing cardiac surgery requiring CPB were randomized to remote ischemic preconditioning of the upper extremity or sham intervention. The end point was combined death, MI, stroke, and acute renal failure during hospitalization, and secondary endpoints were the occurrence of any such event within 90 days. Outcomes were similar between the gro
October 5, 2015
Pts undergoing CABG on-pump were randomized to remote preconditioning (upper arm ischemia) or sham intervention prior to surgical incision. The primary end point was a combination of cardiovascular death, stroke, MI, and revascularization. At 1 year there was no difference between the groups in the incidence of the end point, and other important cl
September 26, 2015
In this RCT, patients at increased risk for cardiac surgery requiring CPB were assigned to steroids at the time of anesthetic induction and again at the time of CPB induction or no steroids. Primary outcomes were 30-day mortality and major morbidity. Steriods had no effect on the primary outcomes. There was no evidence that stero
September 24, 2015
The investigators of this study compared survival of bare metal stent percutaneous coronary intervention (BMS-PCI) versus drug-eluting stent PCI (DES-PCI) versus single artery CABG (SA-CABG) versus multiarterial CABG (MA-CABG) in patients with multivessel coronary artery disease.